<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39411500</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6973</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Infection and drug resistance</Title><ISOAbbreviation>Infect Drug Resist</ISOAbbreviation></Journal><ArticleTitle>Enhancing Predictive Accuracy of Pediatric COVID-19 Mortality: Integrating Clinical Indicators Beyond HCT-ALB [Letter].</ArticleTitle><Pagination><StartPage>4375</StartPage><EndPage>4376</EndPage><MedlinePgn>4375-4376</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IDR.S498364</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Huiye</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hematology, Affiliated Hospital of Guilin Medical University, Guilin, 541001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaotao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hematology, Affiliated Hospital of Guilin Medical University, Guilin, 541001, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Drug Resist</MedlineTA><NlmUniqueID>101550216</NlmUniqueID><ISSNLinking>1178-6973</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors report no conflicts of interest in this communication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411500</ArticleId><ArticleId IdType="pmc">PMC11476366</ArticleId><ArticleId IdType="doi">10.2147/IDR.S498364</ArticleId><ArticleId IdType="pii">498364</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu Y, Li L, Wang W, et al. Hematocrit and albumin levels at admission predict in-hospital mortality in pediatric COVID-19 Omicron Variant patients. Infect Drug Resist. 2024;17:4067–4078. doi:10.2147/IDR.S479580</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S479580</ArticleId><ArticleId IdType="pmc">PMC11416771</ArticleId><ArticleId IdType="pubmed">39309070</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawad B, Adhikari P, Podgornik R, Ching WY. Binding interactions between receptor-binding domain of spike protein and human angiotensin Converting Enzyme-2 in Omicron Variant. J Phys Chem Lett. 2022;13(17):3915–3921. doi:10.1021/acs.jpclett.2c00423</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpclett.2c00423</ArticleId><ArticleId IdType="pmc">PMC9063111</ArticleId><ArticleId IdType="pubmed">35481766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179. doi:10.1056/NEJMc2001737</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pmc">PMC7121626</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Corballis N, Vassiliou VS. Renin-angiotensin-aldosterone inhibitors and COVID-19 Infection. Curr Hypertens Rep. 2022;24(10):425–433. doi:10.1007/s11906-022-01207-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-022-01207-3</ArticleId><ArticleId IdType="pmc">PMC9206216</ArticleId><ArticleId IdType="pubmed">35716247</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905–919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>